|
|
HOT TOPICS IN HYPERTENSION: Issue 1, 2007
Renal protection with telmisartan: a key target when managing hypertension and diabetes
Renal protection with telmisartan: a key target when managing hypertension and diabetes
Giuliano Tocci, Massimo Volpe
Correspondence to:
Massimo Volpe - MD, FAHA, FESC Professor of Cardiology Chair and Division of Cardiology II Faculty of Medicine University ”La Sapienza” of Rome Sant'Andrea Hospital Rome, Italy E-mail: massimo.volpe@uniroma1.it
Summary
- HYPERTENSION: A GROWING HEALTH CARE PROBLEM
- Pathophysiology of hypertension: focus on the renin-angiotensin system
- Hypertension-related target organ damage: factors that drive prognosis
- The continuum from microalbuminuriato renal failure in hypertension
- MODERN PHARMACOLOGICAL APPROACH TO HYPERTENSION
- Beneficial effects of antihypertensive strategies on renal damage
- Angiotensin-converting enzyme inhibitors and renal protection
- Angiotensin II receptor blockers on renal protection
- FOCUS ON TELMISARTAN
- Biochemical and pharmacological properties of telmisartan
- Metabolic properties of telmisartan
- Telmisartan and renal protection: the PROTECTION Program
- HEAD-TO-HEAD COMPARISON BETWEEN ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS
- The ONTARGET/TRANSCEND trial
- CONCLUSIONS
- REFERENCES
If you have a Username and Password, you may already access to this article. Please login below.
If you do not have a Username and Password, click the "Register" button below to purchase this article.
|
|